09/04/2026
🔎 Worth a Read: CSRG Research Highlight
Our latest featured publication, “Development and Initial Validation of the Novel Scleroderma Clinical Trials Consortium Activity Index (SCTC-AI),” introduces an important tool designed to advance the assessment of disease activity in scleroderma clinical trials.
📚 Read. Discover. Learn more.